DrugNews: Court Records Show Rising Lawsuits for Pradaxa as Additional Uses Approved

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Due to the number of families that have filed a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated in a special federal multidistrict litigation court.

Chicago, IL (PRWEB) April 19, 2014

The prescription drug safety advocates at DrugNews.net are alerting patients taking the blood thinner Pradaxa of new information on the site. As the number of lawsuits alleging the drug caused internal bleeding continue to rise, its use has been expanded to include treatment of deep vein thrombosis (DVT) and pulmonary embolism*.

DrugNews is a free resource providing the latest recalls, safety alerts, research and legal news to those taking popular prescription drugs. Visitors can see if others are experiencing similar side effects, avoid potential dangers and decide if they need legal advice.

Pradaxa was approved by the FDA in 2010 to prevent blood clots and strokes in patients with atrial fibrillation. Experts disagree, however, whether it increases risks of internal bleeding.

DrugNews has added research suggesting patients taking newer blood thinners like dabigatran may be 55% more likely to suffer internal bleeding**. The Institute for Safe Medication Practices has also advised bleeding from Pradaxa could be 5 times as likely to cause death***.

Now, DrugNews has learned the FDA has approved the usage of Pradaxa for DVT and pulmonary embolism, in addition to fighting blood clots in patients with atrial fibrillation*. This could add nearly 1 million new prescriptions of the drug amid the current safety concerns*.

Due to the number of families that have filed a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated in a special federal multidistrict litigation court. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

The latest report from the Judicial Panel on Multidistrict Litigation shows the number of lawsuits filed has risen nearly 5% in less than a month, from 2,226 on March 13 to 2,337 as of April 15th****.

Anyone who suffered internal bleeding after taking Pradaxa is encouraged to visit DrugNews.net or speak with a lawyer about their legal options. DrugNews only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugNews.net today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*Fierce Pharma, 4/8/14; fiercepharma.com/story/boehringers-pradaxa-fights-regain-ground-new-clot-fighting-approval/2014-04-08
**Gastroenterology, July 2013; gastrojournal.org/article/S0016-5085(13)00290-4/fulltext
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****JPML, 4/15/14; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-April-15-2014.pdf


Contact